Non-Sterile Compounding Pharmacy Market Outlook 2025–2032: Size, Trends & Players According to a newly published market research report by 24LifeSciences, global non-sterile compounding pharmacy market is valued at USD 595 million in 2026 and is projected to reach USD 694 million by 2034, growing at a compound annual growth rate (CAGR) of 2.3% during the forecast period. Non-sterile compounding involves the customized preparation of medications for oral, topical, nasal, otic, or rectal administration, tailored to meet specific patient needs unavailable in commercial formulations. This practice requires strict adherence to regulatory standards like USP Chapter <795>, ensuring product integrity, accurate dosing, and patient safety. Its critical role in personalized medicine makes it indispensable for populations requiring unique formulations, including pediatric, geriatric, and patients with allergies or sensitivities to standard drug excipients. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9556/non-sterile-compounding-pharmacy-market

According to a newly published market research report by 24LifeSciences, the global medical simulation market was valued at USD 2.43 billion in 2026 and is projected to reach USD 5.73 billion by 2034, growing at a compound annual growth rate (CAGR) of 13.2% during the forecast period. Medical simulation encompasses advanced educational technologies used to train healthcare professionals through experiential learning in risk-free, realistic environments. This field, also known as healthcare simulation, includes various modalities from basic anatomical models and partial task trainers to sophisticated virtual reality (VR) and augmented reality (AR) systems. Its critical role in improving clinical skills, enhancing patient safety, and reducing medical errors continues to drive its adoption across medical education and clinical training worldwide. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/7577/medical-simulation-market

Non-Destructive Medical Technologies Market Size to Reach USD 9.41 Billion by 2032 Global Non-Destructive Medical Technologies market is undergoing steady and technology-driven expansion, reflecting the healthcare sector’s growing reliance on safe, accurate, and minimally invasive diagnostic solutions. Valued at USD 6.82 billion in 2024, the market is projected to reach USD 9.41 billion by 2032, advancing at a CAGR of 5.9% during the forecast period. This growth trajectory is supported by the broader expansion of the global medical devices ecosystem, which continues to prioritize diagnostic precision, patient safety, and workflow efficiency across clinical settings. Access the market report https://www.24lifesciences.com/non-destructive-medical-technologies-market-9555